Request To Download Free Sample of This Strategic Report @ This country research report on Vietnam Smoking Cessation and Nicotine De-addiction Products Market offers comprehensive insights into the ...

The FDA has endorsed ZYN products for sale as a harm reduction measure to help smokers quit. Nonetheless, rising ZYN usage ...

Vaping, Juuling, cloud chasing – we have all most likely heard of electronic cigarettes or vapes. With so many new terms and devices being pushed to market, it can feel hard to keep track of the ...

In January 2025, the US Food and Drug Administration (FDA) authorized the marketing of nicotine pouches to individuals aged 21 years and older. However, the use of nicotine pouches among teens appears ...

When John,* 43, first heard about Zyn from a friend a couple years ago, it struck him as a “much better alternative to chewing [tobacco],” he tells SELF, which he’d previously done on occasion to get ...

For people recovering from substance use disorders, quitting smoking remains one of the most difficult—but most crucial—steps ...

For people recovering from substance use disorders, quitting smoking remains one of the most difficult-but most crucial-steps ...

For people recovering from substance use disorders, quitting smoking remains one of the most difficult—but most crucial—steps toward long-term ...

The Food and Drug Administration (FDA) has approved Yeztugo (aka. lenacapavir or LEN), a twice-a-year injection that stops HIV from replicating inside cells, thereby reducing the risk of ...

FDA's long-standing accelerated approval program generally issues decisions in six months for drugs that treat life-threatening diseases. Regular drug reviews take about 10 months.

Bernie Sanders and Angus King introduced a bill that would ban pharmaceutical manufacturers from using direct-to-consumer advertising, including social media, to promote their products.

Yaqoot Fatima receives funding from NHMRC, MRFF, Beyond Blue and in-kind support from ResMed. Nisreen Aouira does not work for, consult, own shares in or receive funding from any company or ...